报告题目：Myocardin Regulation of Vascular Smooth Muscle Differentiation and Proliferation

报  告 人：Prof. Xi-Long Zheng，University of Calgary

报告时间：4月10日 13：00-14：00

报告地点：闵行校区生物药学楼2-116会议室

联  系 人：谢志平 zxie@sjtu.edu.cn  齐颖新 qiyx@sjtu.edu.cn
 

Bio sketch

       Dr. Zheng is a tenured professor in the Department of Biochemistry & Molecular Biology, the Libin Cardiovascular Institute of Alberta, Cumming School of Medicine at the University of Calgary. He obtained the M.D. and M.Sc. from Hunan Medical University (Central South University) in China in 1986 and 1989, respectively, and Ph.D. from the University of Calgary in 1997. He subsequently undertook postdoctoral training in the State University of New York at Stony Brook and the University of Calgary and a faculty position at the latter institution.

Dr. Zheng is the recipient of many awards, including Alberta Innovates ‒ Health Solutions (AIHS) Senior Scholar Award (2008 ‒ 2015), New Investigator Award of the Heart & Stroke Foundation of Canada (2001 ‒ 2006), Scholarship Award of the Canadian Institutes of Health Research & Hypertension Society of Canada (2001 ‒ 2004), Fellowship Award of the Heart & Stroke Foundation of Canada & AstraZenica Pharma/MRC/PMAC (1999 ‒ 2001). He served on the grant panels of the Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Canada (HSFC) grant panel V and is currently serving on editorial boards of several journals, including BiochemicalJournal.

Dr. Zheng’s research involves the investigation of mechanisms underlying differentiation and proliferation of vascular smooth muscle cells in vitro and in vivo, and how smooth muscle dedifferentiation contributes to vascular disease. The laboratory has made advances in the field of regulation of smooth muscle differentiation and the cell cycle. Dr. Zheng has published more than 100 peer-reviewed articles, many of which appear in high-ranking journals, including PNAS, ATVB, Diabetologia, JBC and Hypertension.